Aer Therapeutics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$5M
- Investors
-
5
Aer Therapeutics General Information
Description
Operator of a biopharmaceutical company intended to treat lung disease with excess mucus and mucus plugs. The company focuses on treating respiratory diseases with significant unmet needs, such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma, enabling researchers to advance the treatment paradigm for mucus-mediated lung diseases.
Contact Information
Website
www.aertherapeutics.comCorporate Office
- 400 West North Street
- Suite 112
- Raleigh, NC 27603
- United States
Corporate Office
- 400 West North Street
- Suite 112
- Raleigh, NC 27603
- United States
Aer Therapeutics Timeline
Aer Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | 05-Feb-2025 | $5M | Completed | Clinical Trials - General | ||
| 3. Later Stage VC (Series B) | Completed | Clinical Trials - General | ||||
| 2. Later Stage VC (Series A) | 09-Dec-2022 | $36M | $36M | Completed | Clinical Trials - General | |
| 1. Grant | $18M | Completed | Startup |
Aer Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Aer Therapeutics Comparisons
Industry
Financing
Details
Aer Therapeutics Competitors (3)
One of Aer Therapeutics’s 3 competitors is Avalyn Pharma, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Avalyn Pharma | Venture Capital-Backed | Cambridge, MA | ||||
| Verona Pharma | Private Debt Financed | London, United Kingdom | ||||
| Savara | Formerly VC-backed | Langhorne, PA |
Aer Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aer Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aer Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Pappas Capital | Venture Capital | Minority | ||
| Canaan Partners | Venture Capital | Minority | ||
| Hatteras Venture Partners | Venture Capital | Minority | ||
| OrbiMed | Growth/Expansion | Minority | ||
| National Institutes of Health | Government |
Aer Therapeutics FAQs
-
When was Aer Therapeutics founded?
Aer Therapeutics was founded in 2014.
-
Where is Aer Therapeutics headquartered?
Aer Therapeutics is headquartered in Raleigh, NC.
-
What is the size of Aer Therapeutics?
Aer Therapeutics has 10 total employees.
-
What industry is Aer Therapeutics in?
Aer Therapeutics’s primary industry is Drug Discovery.
-
Is Aer Therapeutics a private or public company?
Aer Therapeutics is a Private company.
-
What is the current valuation of Aer Therapeutics?
The current valuation of Aer Therapeutics is .
-
What is Aer Therapeutics’s current revenue?
The current revenue for Aer Therapeutics is .
-
How much funding has Aer Therapeutics raised over time?
Aer Therapeutics has raised $41M.
-
Who are Aer Therapeutics’s investors?
Pappas Capital, Canaan Partners, Hatteras Venture Partners, OrbiMed, and National Institutes of Health have invested in Aer Therapeutics.
-
Who are Aer Therapeutics’s competitors?
Avalyn Pharma, Verona Pharma, and Savara are competitors of Aer Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
